Stellate Ganglia
Cross-source consensus on Stellate Ganglia from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Highlighted claims
- Most cardiac sympathetic innervation arises from the stellate ganglia, which form by fusion of the lower cervical and first thoracic sympathetic ganglia. — Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia
- In vivo stellate ganglion stimulation lowers the fibrillatory threshold and induces ventricular arrhythmia. — Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia
- Stellate ganglion stimulation increases the T-peak to T-end interval, an independent ECG predictor of sudden cardiac death risk. — Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia
- Stellate ganglia removed from patients with recurrent ventricular arrhythmias show structural and immune changes including larger neurons, increased synaptic density, oxidative stress, and T-cell infiltration. — Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia
- Stellate ganglion glial activation in mice increases sympathetic output to the heart, heart rate, myocardial contraction, and cardiac norepinephrine release. — Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia